Deal could swell Unilever’s debt pile says ratings agency Fitch
Unilever has been warned that buying GlaxoSmithKline’s consumer products arm is likely to substantially swell its debt pile and could trigger a “multi-notch downgrade” to its credit rating.
Ratings agency Fitch said Unilever would not be able to keep hold of its current A rating with a stable outlook beyond 2024-2025, and would be cut to BBB, if it were to acquire GSK’s consumer products division or another large business.
